Market Overview

Anti-Obesity Drugs Market: Global Strategic Business Report 2018 - High Drug Development Costs is a Major Setback - ResearchAndMarkets.com

Share:

The "Anti-Obesity
Drugs - Global Strategic Business Report"
report has been added
to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada,
Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates
and forecasts are provided for the period 2015 through 2024.

This report analyzes the worldwide markets for Anti-Obesity Drugs in US$
Million.

The report profiles 25 companies including many key and niche
players such as:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • GlaxoSmithKline PLC (UK)
  • Eisai Co. Ltd. (Japan)
  • Novo Nordisk A/S (Denmark)
  • Rhythm Pharmaceuticals (USA)
  • VIVUS Inc. (USA)

Key Topics Covered

1. Introduction, Methodology & Product Definitions

2. Industry Overview

3. Growth Drivers and Market Trends

  • Alarming Rise in Global Obesity Levels - The Major Growth Factor
  • Classification of BMI
  • Exponential Increase in Urban Population
  • Rising Incidence of Chronic Diseases Associated with Obesity Drive the
    Market Expansion
  • Growing Middle Class Population to Drive the Market Growth
  • Childhood Obesity - A Market with Unmet Needs
  • Commercial Weight-Loss Companies Foray into the Market
  • Online Drug Stores Boost Sales
  • Barriers to Development of Effective Drugs
  • Regulatory Additions - A Barrier to Entry?
  • High Drug Development Costs - A Major Setback
  • Weight Loss Alternatives - A Market Dampener

4. Select Research Initiatives

5. Obesity - An Introduction

6. Anti-Obesity Drugs - An Insight

7. Competitive Landscape

7.1 Focus on Select Global Players

7.2 Recent Industry Activity

8. Global Market Perspective

Total Companies Profiled: 25 The United States (9)

  • Japan (2)
  • Europe (8)
    • Germany (1)
    • The United Kingdom (1)
    • Italy (1)
    • Rest of Europe (5)
  • Asia-Pacific (Excluding Japan) (6)

For more information about this report visit https://www.researchandmarkets.com/research/7pmxl6/antiobesity?w=4

View Comments and Join the Discussion!